Though the firm is among the four largest animal drug producers, Elanco faces challenges in evolving into a more dominant and profitable competitor. The firm’s stated strategy relies heavily on ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025. Elanco will also conduct a conference call on ...

GREENFIELD, Ind., Feb. 4, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2024 financial results on Tuesday, February 25 ...